Cerevel Therapeutics Hldg Inc
(CERE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 12-2018 | 05-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -79,925 | -53,208 | -128,389 | -115,909 | -5,976 |
| Depreciation Amortization | 285 | 95 | 177 | 19 | 307 |
| Accounts receivable | N/A | N/A | N/A | N/A | 193 |
| Accounts payable and accrued liabilities | 3,300 | 4,806 | N/A | N/A | N/A |
| Other Working Capital | 6,446 | 4,471 | 343 | 1,872 | -2,600 |
| Other Operating Activity | 13,877 | 14,382 | 57,149 | 106,973 | -3,710 |
| Operating Cash Flow | $-56,017 | $-29,454 | $-70,720 | $-7,045 | $-11,786 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,042 | -2,556 | -1,099 | -110 | 572 |
| Net Acquisitions | N/A | N/A | 0 | -10,952 | N/A |
| Investing Cash Flow | $-4,042 | $-2,556 | $-1,099 | $-11,062 | $572 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 6,281 |
| Other Financing Activity | -1,524 | 0 | 60,058 | 113,550 | 966 |
| Financing Cash Flow | $-1,524 | $N/A | $60,058 | $113,550 | $7,247 |
| Exchange Rate Effect | N/A | N/A | 0 | 0 | 24 |
| Beginning Cash Position | 83,682 | 83,682 | 95,443 | 0 | 8,095 |
| End Cash Position | 22,099 | 51,672 | 83,682 | 95,443 | 4,152 |
| Net Cash Flow | $-61,583 | $-32,010 | $-11,761 | $95,443 | $-3,943 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,017 | -29,454 | -70,720 | -7,045 | -11,786 |
| Capital Expenditure | -4,042 | -2,556 | N/A | N/A | -85 |
| Free Cash Flow | -60,059 | -32,010 | -70,720 | -7,045 | -11,871 |